Icon PLC, the Irish-headquartered clinical research giant, has warned the markets that a large Covid-19 vaccine study it recently told investors about was delayed by its sponsor. In February ...

Executives in Dublin-based Icon plc, which runs clinical trials worldwide, had “motive and opportunity to defraud investors” when they sold almost $78 million (€74.3 million) worth of shares ...